Cargando…

Bladder cancer recurrence surveillance by urine metabolomics analysis

Non Muscle Invasive Bladder Cancer (NMIBC) is among the most frequent malignant cancers worldwide. NMIBC is treated by transurethral resection of the bladder tumor (TURBT) and intravesical therapies, and has the highest recurrence rate among solid tumors. It requires a lifelong patient monitoring ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loras, A., Trassierra, M., Sanjuan-Herráez, D., Martínez-Bisbal, M. C., Castell, J. V., Quintás, G., Ruiz-Cerdá, J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004013/ https://www.ncbi.nlm.nih.gov/pubmed/29907864 http://dx.doi.org/10.1038/s41598-018-27538-3

Ejemplares similares

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2019)

New bladder cancer non-invasive surveillance method based on voltammetric electronic tongue measurement of urine
por: Monreal-Trigo, Javier, et al.
Publicado: (2022)

Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomic analysis
por: Martínez-Sena, Teresa, et al.
Publicado: (2019)

Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
por: Loras, Alba, et al.
Publicado: (2021)

Comparing Targeted vs. Untargeted MS(2) Data-Dependent Acquisition for Peak Annotation in LC–MS Metabolomics
por: Ten-Doménech, Isabel, et al.
Publicado: (2020)

Plasma sample based analysis of gastric cancer progression using targeted metabolomics
por: Lario, Sergio, et al.
Publicado: (2017)

The assessment of the potential hepatotoxicity of new drugs by in vitro metabolomics
por: Quintás, Guillermo, et al.
Publicado: (2023)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer
por: Lamarca, Angela, et al.
Publicado: (2012)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
por: Wittmann, Bryan M., et al.
Publicado: (2014)

Pitfalls to be considered on the metabolomic analysis of biological samples by HR-MAS
por: Esteve, Vicent, et al.
Publicado: (2014)

Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved
por: Martínez-Sena, Teresa, et al.
Publicado: (2023)

A targeted metabolic analysis of football players and its association to player load: Comparison between women and men profiles
por: Rodas, Gil, et al.
Publicado: (2022)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Urine Biopsy—Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer
por: Satyal, Uttam, et al.
Publicado: (2019)

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021)

Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
por: Lin, Jia-You, et al.
Publicado: (2021)

Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019)

Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
por: Charpentier, Marine, et al.
Publicado: (2021)

The Human Urine Metabolome
por: Bouatra, Souhaila, et al.
Publicado: (2013)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Pre- and Post-Resection Urine Metabolic Profiles of Bladder Cancer Patients: Results of Preliminary Studies on Time Series Metabolomics Analysis
por: Jacyna, Julia, et al.
Publicado: (2022)

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer
por: Reinert, Thomas
Publicado: (2012)

Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey
por: Moreno-Torres, Marta, et al.
Publicado: (2021)

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020)

Urine Metabolome during Parturition
por: Gevi, Federica, et al.
Publicado: (2020)

Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2015)

Cost Analysis of the Automated Examination of Urine with the Sysmex UN-Series™ in a Spanish Population
por: Herráez Carrera, Óscar, et al.
Publicado: (2020)

Catarrh of the Bladder; Albumen in the Urine
por: Thompson, Henry
Publicado: (1880)

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study
por: Batista, Rui, et al.
Publicado: (2019)

Rapid Detection of Recurrent Non-Muscle Invasive Bladder Cancer in Urine Using ATR-FTIR Technology
por: El-Falouji, Abdullah I., et al.
Publicado: (2022)

A metabolic readout of the urine metabolome of COVID-19 patients
por: Marhuenda-Egea, F. C., et al.
Publicado: (2023)

Magnetic Resonance Microscopy Contribution to Interpret High-Resolution Magic Angle Spinning Metabolomic Data of Human Tumor Tissue
por: Martínez-Bisbal, M. Carmen, et al.
Publicado: (2011)

Changes in the urine volatile metabolome throughout growth of transplanted hepatocarcinoma
por: Kochevalina, M. Yu., et al.
Publicado: (2022)

UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma
por: Wang, Zhan, et al.
Publicado: (2019)

Multiple Chromatographic Analysis of Urine in the Detection of Bladder Cancer
por: Džubinská, Daniela, et al.
Publicado: (2021)

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine
por: Descotes, Françoise, et al.
Publicado: (2017)

Retention of Urine. Puncture of the Bladder with Dieulafoy's Instrument
por: L'Abbe, M.
Publicado: (1872)

Cannot write session to /tmp/vufind_sessions/sess_n5v8ni8q4aefapk3plkn1alefj